DD
48
2
HD
28
8
PGR
39
2
BF.B
35
3
FLR
33
-3
IP
34
10
LH
55
3
FTI
76
5
UNP
49
4
ESS
31
3
ZION
75
2
PX
58
3
LMT
67
5
EQT
48
-6
SO
57
7
SPG
48
3
MPC
65
5
CL
40
9
QRVO
53
3
MSI
40
5
DD
48
2
HD
28
8
PGR
39
2
BF.B
35
3
FLR
33
-3
IP
34
10
LH
55
3
FTI
76
5
UNP
49
4
ESS
31
3
ZION
75
2
PX
58
3
LMT
67
5
EQT
48
-6
SO
57
7
SPG
48
3
MPC
65
5
CL
40
9
QRVO
53
3
MSI
40
5
Financhill
Back

iShares US Regional Banks ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
74

IAT
iShares US Regional Banks ETF

Last Price:
$57.75
Seasonality Move:
-2.05%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$55.51
Seasonality Move:
-11.9%
Buy
74
iShares US Regional Banks ETF (IAT) is a Buy

Is iShares US Regional Banks ETF a Buy, Sell or Hold?

  • The current iShares US Regional Banks ETF [IAT] share price is $57.79. The Score for IAT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • IAT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IAT Stock Price Chart

What is iShares US Regional Banks ETF's stock price today?

  • The iShares US Regional Banks ETF share price today is $57.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IAT is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

IAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.21 Buy
Relative Strength Index (14 RSI): 67.72 Buy
Chaikin Money Flow: 57124 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.99 - 57.01) Buy
Bollinger Bands (100): (50.03 - 54.89) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

IAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.61 Buy
20-day SMA: 56.09 Buy
50-day SMA: 52.8 Buy
200-day SMA: 49.9 Buy
8-day EMA: 56.84 Buy
20-day EMA: 55.79 Buy
50-day EMA: 53.34 Buy
200-day EMA: 35.25 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

iShares US Regional Banks ETF Earnings Growth & IAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

iShares US Regional Banks ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):